C-type natriuretic peptide: a potential marker of chronic kidney disease in diabetes

Status: Complete
Year: 2018
Funded: $5,000
Grant Type: Grant in Aid

There is an urgent need for an early test for diabetic kidney disease enabling beneficial interventions before irreversible kidney damage occurs. A new test developed in Christchurch measures NTproCNP in urine, which increases when the kidneys are injured, and may prove to be a useful early marker of kidney injury.

Researcher // Associate Professor Helen Lunt – Canterbury District Health Board

Associate Professor Lunt is currently a Diabetes Physician at the Christchurch Diabetes Centre, a Clinical Director of the Health Innovation Hub at the Canterbury District Health Board, and a Clinical Associate Professor at the University of Otago, Christchurch.

More About Associate Professor Helen Lunt

What is Diabetes?

Diabetes is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Insulin is a hormone made by the pancreas, that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods are broken down into glucose in the blood. Insulin helps glucose get into the cells.Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood (known as hyperglycaemia). Over the long-term high glucose levels are associated with damage to the body and failure of various organs and tissues.

0 %
Global prevalence of diabetes among adults over 18 years in 2014.
0 m
It has been estimated that 2 million deaths were directly caused by diabetes in 2016.
The number of people with diabetes had risen from 108 million in 1980 to 422 million in 2014.
0 th
Diabetes was estimated as the seventh leading cause of death in 2016.

Stay in touch with CMRF

// Get all the latest news and insights to your inbox